Share this page
PR Hub
Breaking News
|
Entertainment
|
Sports
|
Business
|
Politics
|
Science
|
Technology
|
Odd News
|
Health
|
Law
More
Crime Watch
Accidents & Disasters
Religion
Education
Travel
Stem Cell Research
Diabetes
Eye Care
Newsletter
Pet
Press Release
Voice
Microblog
Arqule Inc. And Daiichi Sankyo Co. Ltd.
ARQ 197 in combination with erlotinib showed promising overall survival, consistent with efficacy signal seen in progression-free survival
WOBURN, Massachusetts and TOKYO, June 7, 2010 - ArQule, Inc.
MORE..
Older News
S
M
T
W
T
F
S
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
